The CIP Community
Your first point of contact will be the CIP Administrator
Email: cip@ucalgary.ca
Interim Program Director
Dr. Jacqueline McMillan, MD MSc FRCPC
Email: mcmilljm@ucalgary.ca
Interim Assistant Program Director
Dr. Aliya Kassam, PhD
CIP Administrator
(available Tues-Thurs, 8am-4pm)
Stacey Anderson-Redick
(403) 220-7318
Email: cip@ucalgary.ca
CIP Ombudsperson
Dr. Laura Hinz
Email: Laura.Hinz@albertahealthservices.ca
Clinician Investigator Program Office
Cumming School of Medicine | University of Calgary
HRIC 1AC62
3230 Hospital Drive NW
Calgary, Alberta T2N 4N1
Assistant Professor in Medicine and Community Health Sciences, Dr. McMillan studies aging, frailty, and health services using knowledge synthesis and large health data, including prospective and administrative datasets. She is local Principal Investigator for the Canadian Longitudinal Study on Aging and Co-Chair of the CIHR Clinical Trials Group HIV and Aging Research Development Team. Her work focuses on older adults living with HIV, including frailty, falls, polypharmacy, cognitive decline, social isolation, and loneliness.
Dr. Kiss is a clinician-scientist and Professor in Clinical Neurosciences/ Psychiatry at the Hotchkiss Brain Institute. Her research encompasses mechanisms of action of deep brain stimulation (DBS) and new neuromodulation therapies (focused ultrasound) in animal models and humans, somatosensory restoration techniques, electrophysiological and imaging markers of neuropsychiatric disease, and clinical trials of novel neuromodulatory techniques and targets.
Dr. Kassam is interested in the intersection of medical education with health services, specifically in the areas of how medical education impacts patient-centered care and patient safety. She is the Research Lead in Postgraduate Medical Education and has educational research in three primary areas: assessment of non-medical competencies within residents; examining the structure of residency education programs and the application of evidence based practice in medical education. She has taught courses in Research Design and Statistics as well as Systematic Reviews and Meta-Analysis.
Cardiovascular & Respiratory Sciences Graduate Program
Dr. Andrew Braun, PhD, is a professor in Physiology and Pharmacology and director of the Cardiovascular and Respiratory Sciences Graduate Program. His research examines how resistance arteries regulate blood flow and blood pressure, focusing on endothelial signaling, vascular smooth muscle contractility, nitric oxide/cGMP pathways, membrane hyperpolarization, and calcium-activated K+ channels. His work also studies KCa channel modulators as potential strategies to improve cardiovascular function in disease models, including type 2 diabetes.
Community Health Sciences
Dr. Marshall is an Associate Professor in Community Health Sciences and Graduate Program Director, with interdisciplinary training in psychology, social work, and community health. His research builds on work with queer and trans communities in mental health, harm reduction, and sexual health. Current projects focus on research production, knowledge synthesis, and ethical research with individuals and communities experiencing marginalization, including 2SLGBTQ+ people. He is committed to collaborative mentorship and supporting groups historically underrepresented in academia.
Internal Medicine
Dr. Kara Nerenberg is an Associate Professor and Clinician-Scientist at the University of Calgary working in the areas of General Internal Medicine and Obstetric Medicine. Dr. Nerenberg’s clinical and research interests focus prevention of cardiovascular diseases in women after common pregnancy complications, mainly the hypertensive disorders of pregnancy and gestational diabetes. Her research is supported by CIHR and Heart & Stroke’s Women’s Heart and Brain Health Mid-Career Research Chair through which she founded and leads the Canadian Postpregnancy Clinical Network.
Cardiac Sciences
Dr. Raj runs an active research program in Human Autonomic Physiology. His primary research interests relate to understanding and better treating postural orthostatic tachycardia syndrome (POTS), vasovagal syncope, and orthostatic hypotension.
Dr. Morris Scantlebury is Professor in the Departments of Pediatrics and Clinical Neurosciences at the University of Calgary. He also is a pediatric neurologist at the ACH and is a member of the Alberta Children’s Hospital Research Institute, Hotchkiss Brain Institute and Owerko Center. Dr. Scantlebury has a broad background in pediatric epilepsy research. His current research focus is to identify new treatments for the catastrophic infantile spasms syndrome. Dr. Scantlebury also investigates the mechanisms of febrile seizures, which is the most common form of seizures to affect children.
Dr. Swamy is a spine surgeon, Department of Surgery, with clinical and research interests in adult spinal deformity and common degenerative spinal disorders. His work focuses on developing less-invasive reconstructions and team-based approaches for complex spinal deformity surgery. His research aligns with his clinical practice and involves a multidisciplinary team of engineers, biologists, and surgeons studying lumbar disc herniation, sciatica, degenerative spondylolisthesis, and degenerative scoliosis.
Orthopaedic trauma surgeon Prism Schneider spends half her time performing surgery and treating orthopaedic trauma cases, and the other half doing research on how inflammation affects fracture healing and an individual’s risk of developing blood clots or excessive bleeding. Some of this work is done in a lab, using a pre-clinical model to study joint injury and inflammation. But most of her research involves leading clinical trials to find better medications and surgical treatments to control inflammation and optimize healing after injury.
Dr. Lee's primary research objectives are to develop innovative immune cell-based treatments for acute myeloid leukemia using DNTs that can make a positive impact on cancer patients' lives. Additionally, he seeks to uncover the underlying mechanisms responsible for DNT's anti-cancer effects.
Dr. Condliffe is an assistant professor in Clinical Neurosciences, Physical Medicine and Rehabilitation. Her clinical work and research focus on improving interventions that promote neuroplastic change and reduce the impacts of long-term neurodisabilities, including cerebral palsy. As a biomedical engineer, neurophysiologist, and physiatrist, she leads the PONI lab, using robotic walking aids, neurophysiologic tools, and clinical technologies for assessment, rehabilitation, and assistive devices. Current projects include robotic walking, power training, gait analysis, and spasticity assessment.